Gelofusine® – A colloidal volume replacement fluid based on 4% modified fluid gelatin

• Provides a wide range of therapeutic indications
• Provides a readily controllable volume effect over 3-4 hours
• Provides an immediate increase in intravascular volume and re-establishes disturbed haemodynamics
• Is completely degraded, degradation products are rapidly excreted
• Does not effect blood coagulation
• Is compatible with blood and blood products
• Has no dose limit
• Lowers the risk of hyperchloremic acidosis due to the reduced, more physiological concentration of chloride ions